FDA Issues Strongest Warning On Intravenous Anemia Drug
The U.S. Food and Drug Administration Monday issued its strongest warning regarding potentially fatal allergic reactions to a drug used to treat iron-deficiency anemia in adults with chronic kidney disease after...To view the full article, register now.
Already a subscriber? Click here to view full article